Michael Gelband’s Innoviva INVA Stock Holding History

Michael Gelband’s Portfolio INVA Stock Details INVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-97,277	Closed	-$1.76M	–	1702
2025 Q1	$1.76M	Sell	97,277 -41,412	-30%	-$742K	0.02%	736
2024 Q4	$2.41M	Sell	138,689 -204,870	-60%	-$3.93M	0.02%	653
2024 Q3	$6.63M	Buy	343,559 +75,894	+28%	+$1.4M	0.04%	317
2024 Q2	$4.39M	Sell	267,665 -16,550	-6%	-$257K	0.03%	449
2024 Q1	$4.33M	Buy	+284,215	New	+$4.46M	0.03%	437
2023 Q4	–	Sell	-68,923	Closed	-$895K	–	1746
2023 Q3	$895K	Sell	68,923 -36,164	-34%	-$470K	0.01%	1002
2023 Q2	$1.34M	Sell	105,087 -152,219	-59%	-$1.91M	0.01%	986
2023 Q1	$2.9M	Buy	257,306 +100,140	+64%	+$1.22M	0.02%	737
2022 Q4	$2.08M	Sell	157,166 -47,487	-23%	-$624K	0.03%	626
2022 Q3	$2.38M	Buy	204,653 +49,144	+32%	+$674K	0.03%	717
2022 Q2	$2.29M	Buy	155,509 +86,270	+125%	+$1.41M	0.03%	726
2022 Q1	$1.34M	Buy	69,239 +49,084	+244%	+$877K	0.02%	975
2021 Q4	$348K	Buy	+20,155	New	+$343K	﹤0.01%	1595
2020 Q4	–	Sell	-22,318	Closed	-$233K	–	2150
2020 Q3	$233K	Buy	+22,318	New	+$284K	﹤0.01%	1407

Other funds holding INVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $178M AUM 118.43% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $5.02B AUM 66.06% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Michael Gelband's INVA Position: Q2 2025 in Review

Michael Gelband sold out of Innoviva (INVA) in Q2 2025, closing a stake of 97,277 shares — an estimated $1.76M sold.

Michael Gelband first reported a position in INVA in Q3 2020 and held it in 14 quarters. The position peaked at $6.63M in Q3 2024. 266 funds tracked by Wall St. Rank hold INVA as of Q2 2025.

Michael Gelband reported no remaining Innoviva position as of Q2 2025 after selling out during the quarter.
Michael Gelband sold 97,277 Innoviva shares in Q2 2025, an estimated $1.76M.
Michael Gelband first reported a position in Innoviva in Q3 2020 and held it in 14 quarters.
Michael Gelband's Innoviva position peaked at $6.63M in Q3 2024.
266 funds tracked by Wall St. Rank held Innoviva as of Q2 2025.

Based on ExodusPoint Capital Management's 13F filing for Q2 2025, filed 13 Aug 2025.